X2RJ3RA
Replacement Tricuspid Valve to New Technology Group 10 with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | R Replacement |
| Body Part | J Tricuspid Valve |
| Approach | 3 Percutaneous |
| Device | R Multi-plane Flex Technology Bioprosthetic Valve |
| Qualifier | A New Technology Group 10 |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
This family involves implanting biological or synthetic material that takes over the physical structure and function of all or part of a cardiovascular structure, using a device recently designated as new technology. A well-known example is a transcatheter aortic valve replacement performed with a next-generation valve system delivered through a catheter rather than open surgery, taking over the role of the patient's diseased native valve. These procedures are typically offered to patients whose anatomy or surgical risk makes the newer device or delivery approach preferable to established alternatives.
The underlying clinical rationale mirrors any replacement procedure: the native structure has failed or degraded to the point that its function must be physically taken over by the substitute material.
Anatomy & Axis Detail
Tricuspid Valve
The tricuspid valve sits between the right atrium and right ventricle and prevents backflow of blood into the atrium during ventricular contraction; severe regurgitation here has historically been undertreated because open surgical repair or replacement carries substantial risk in patients with significant comorbidities or prior cardiac surgery. A New Technology Replacement of this valve typically refers to a transcatheter device delivered percutaneously, most often through the femoral vein, that is anchored within the native tricuspid annulus to replace valve function without open-heart surgery. This approach is generally reserved for patients with severe symptomatic regurgitation who are considered high risk for conventional surgery. Documentation should confirm that the native valve tissue is functionally replaced by the implanted device rather than repaired or restricted in place.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Multi-plane Flex Technology Bioprosthetic Valve
This value describes a bioprosthetic heart valve incorporating a frame engineered with multi-plane flexibility, allowing it to conform to irregular or non-circular annular anatomy during transcatheter implantation. It is distinguished from standard rigid-frame bioprosthetic valves by this adaptive design intended to improve seating and reduce paravalvular leak. The qualifier applies specifically to valves built with this flexible multi-plane technology.
Qualifier: New Technology Group 10
New Technology Group 10 flags a procedure as part of the 2023 batch of add-on codes recognized under the New Technology section. The value itself carries no information about the device or drug involved; that comes from the table, body part, and approach values alongside it. Coders should not confuse it with Group 9 or Group 11, which cover the cohorts approved in the years immediately before and after.
Coding & Documentation
Coders need documentation identifying the specific replacement device by name, the approach used to deliver it, and confirmation that it physically substitutes for the body part rather than merely reinforcing it. A common error is assigning the standard Cardiovascular section Replacement code when the device actually qualifies for New Technology status, or the reverse, using a New Technology code for a device whose table entry has since been retired or superseded. Coders should also verify the qualifier correctly reflects the number of devices or valve components involved when multiple components are placed in the same session.
Commonly Confused With
This is often confused with Supplement, where the deciding question is whether the material replaces the structure entirely or simply reinforces and augments an existing structure that is left largely in place. It is also distinguished from the standard-section valve or vessel replacement codes purely by the device's inclusion in the New Technology table for the applicable code set year.